Asia Pacific Ureteral Stents Market

Asia Pacific Ureteral Stents Market Size

The size of the Asia Pacific ureteral stents market was valued at USD 92.44 million in 2024 and is projected to reach USD 204 million by 2033, growing at a CAGR of 9.18% from 2024 to 2033.

MARKET DRIVERS

Rising Urological Disorders and Unhealthy Lifestyles Drive Ureteral Stents Demand in Asia Pacific

Due to the rising prevalence of urological disorders, government measures to strengthen the healthcare system, and increased disposable money among the middle-class population, Asia Pacific offers significant potential. A ureteral stent is a small hollow tube put into the ureter to relieve blockages in the urine flow of the kidney. Urolithiasis (kidney and ureteral stones) and urine incontinence are becoming more common around the region due to many reasons, such as increased calcium in the diet, alcohol consumption, and unhealthy lifestyles.

Ureteroscopy and ureterorenoscopy, among other things, need a ureteral stent to treat kidney stones, which is driving the market. Negative lifestyle behaviors such as alcohol consumption and an increase in the number of smokers and an obese population with dietary abnormalities are a few of the variables that contribute to such disorders or conditions. After the kidney transplant, a ureteral stent is implanted in the patient's body for a few days to allow the newly transplanted kidney to acclimatize to the patient's body.

Increasing Kidney Transplants and UTI Cases Propel Demand for Ureteral Stents in Asia Pacific

The demand for ureteral stents has increased due to the rising number of kidney transplants and issues with renal dysfunction. It is expected to fuel the market for ureteral stents during the next few years. Furthermore, increased kidney transplants, the geriatric population, and developments in stent composition materials are projected to drive market growth. Due to a higher frequency of urinary tract infections and higher adoption of ureteral stents, the urinary tract infection segment is expected to grow significantly in the ureteral stents market.

MARKET RESTRAINTS

The market's expansion is restricted by a shortage of experienced specialists and the adverse side effects connected with the usage of ureteral stents.

REPORT COVERAGE

COUNTRY LEVEL ANALYSIS

Geographically, Asia Pacific is expected to have the highest CAGR among others. A high aging population with kidney-related disorders, increased urological procedures, and improving healthcare infrastructure in this nation are all driving the market. Furthermore, the expanding medical tourism industry in developing countries such as India, China, and Japan is expected to boost market growth.

In addition, increased government healthcare spending, increased number of hospitalizations, enhanced reimbursement scenarios, and low ureteral stent manufacturing costs are a few other factors supporting the market's expansion in this area. Furthermore, factors driving the adoption of ureteral stents technology include an increase in the incidence of urological diseases caused by microorganism colonization or a sedentary lifestyle, an increase in the geriatric population, and technological advancements in stent composition materials.

In addition, more effective and better outcomes for urinary and renal problems have resulted from technological developments in ureteral stents due to biodegradable polymers. Furthermore, throughout the operation, leading companies are focused on lowering stent migration, ureterovesical reflux, and tissue irritation, which is expected to boost the market growth.

KEY MARKET PLAYERS

Top Companies leading the Asia Pacific Ureteral Stents Market Profiled in the Report are UteraC. R. Bard, Inc., Penn Medical, Cook Medical Inc., Boston Scientific Corporation and Medline Industries, Inc.

MARKET SEGMENTATION

This research report on the Asia Pacific Ureteral Stents Market has been segmented and sub-segmented into the following categories.

By Type

• Expandable Stent
• Double pigtail stent (JJ Stent))

By Patients Sex

• Male
• Female

By End User

• Hospital
• Clinical

By Medical Situation

• Kidney Stones
• Kidney Failures
• Tumors

By Country

• India
• China
• Japan,
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of Asia Pacific